Skip to main content
. 2013 Dec 24;2(2):285–291. doi: 10.3892/mco.2013.233

Table III.

mRNA expression levels of COL23A1 and COL24A1 in HNSCC samples (n=70).

Patient and tumor characteristics (n=70) COL23A1 expression levels P-valueb COL24A1 expression levels P-valueb
Age (years)
 <70 (50) 1.84±3.17 0.200 22.85±29.60 0.104
 ≥70 (20) 0.95±1.77 39.28±62.86
Gender
 Male (55) 1.63±2.32 0.694 31.98±27.12 0.062
 Female (15) 1.58±3.01 26.33±45.17
Smoking status
 Non-smoker (22) 1.78±4.11 0.939 20.67±23.39 0.257
 Smoker (48) 1.50±2.11 30.69±47.91
Alcohol exposure
 No (29) 1.33±2.01 0.716 25.53±33.38 0.703
 Yes (41) 1.77±3.33 28.97±47.25
Tumor size
 T1–2 (21) 0.71±0.92 0.238 39.66±60.84 0.045a
 T3–4 (49) 1.96±3.30 22.35±29.75
Lymph-node status
 N0 (36) 1.29±1.83 0.577 23.94±23.19 0.930
 N+ (34) 1.90±3.65 31.36±55.31
Tumor stage
 I, II, III (35) 1.38±1.80 0.819 25.12±32.42 0.438
 IV (35) 1.79±3.64 29.97±49.86

Data are expressed as means ± standard deviation.

a

P<0.05.

b

Mann-Whitney U test.

HNSCC, head and neck squamous cell carcinoma. COL21A1, collagen type XXI α1 mRNA; COL23A1, collagen type XXIII α1 mRNA.